10-Q: Panamera Holdings Reports Net Loss for Quarter Ended January 31, 2025, Amid Shift in Business Strategy

Panamera Holdings Corporation reports a net loss of $100,015 for the three months ended January 31, 2025, as it transitions its business focus towards environmental services, emerging technologies, and individual health choices.

Summary

• Panamera Holdings Corporation reported a net loss of $100,015 for the three months ended January 31, 2025, compared to a net loss of $41,647 for the same period in 2024.
• For the six months ended January 31, 2025, the company's net loss was $191,076, compared to $104,639 for the same period in 2024.
• Revenues for the three months ended January 31, 2025, were $39,231, all from related party sales, compared to no revenue in the same period of 2024.
• Revenues for the six months ended January 31, 2025, were $82,799, including $74,894 from related party sales, compared to no revenue in the same period of 2024.
• The company's operating expenses for the three months ended January 31, 2025, were $116,586, compared to $42,087 in 2024.
• Operating expenses for the six months ended January 31, 2025, were $230,805, compared to $106,998 in 2024.
• The company is shifting its business focus from healthcare consulting to environmental services, emerging technologies, and individual health choices.
• The company has a working capital deficiency of $343,826 as of January 31, 2025.
• The company intends to fund operations through debt and/or equity financing arrangements and related party advances.
• There is substantial doubt about the company's ability to continue as a going concern.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to the company's significant net losses, working capital deficiency, and going concern uncertainty, despite efforts to pursue new business opportunities.

Positives

• The company generated $82,799 in revenue for the six months ended January 31, 2025, compared to no revenue in the same period last year.
• The company is actively seeking new business opportunities in potentially high-growth sectors.
• The company obtained $275,000 in connection with two stock subscription agreements during February 2025.

Negatives

• The company reported a significant net loss of $191,076 for the six months ended January 31, 2025.
• The company has a substantial working capital deficiency of $343,826.
• Operating expenses have increased significantly.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• The company relies heavily on related party transactions for revenue and financing.

Risks

• The company's ability to continue as a going concern is uncertain.
• The company's reliance on related party transactions poses a potential conflict of interest.
• The company's lack of internal controls over financial reporting could lead to errors in financial statements.
• The company faces competition from entities with greater financial, technical, and managerial capabilities.
• The company's limited capital may hinder its ability to adequately evaluate potential business opportunities.

Future Outlook

The company intends to fund operations through debt and/or equity financing arrangements and related party advances, while pursuing business opportunities in environmental services, emerging technologies, and individual health choices. Management intends to raise additional funds through public or private placement offerings.

Management Comments

• Prior management intended to offer management and consulting services to healthcare organizations, but current management have redirected our efforts now to pursuing business opportunities including but not limited to the environmental services industry, emerging innovative technologies and individual health choices led by innovation with integration.
• We now intend to look for other business opportunities to implement and/or operating companies with which to engage in a business combination including but not limited to the environmental services industry, emerging innovative technologies and individual health choices led by innovation with integration.

Industry Context

The company's shift in focus reflects a broader trend of companies seeking opportunities in emerging sectors like environmental services and innovative technologies. However, the company's financial challenges and reliance on related party transactions may make it difficult to compete effectively in these markets.

Comparison to Industry Standards

• Given the company's small size and shift in business strategy, direct comparisons to industry standards are challenging.
• Many small companies in the environmental services and technology sectors rely on venture capital or private equity funding to support their growth.
• Panamera's reliance on related party financing is less common and may raise concerns about corporate governance.
• Compared to established consulting firms, Panamera's revenue is minimal, reflecting the impact of discontinuing its healthcare consulting business.

Legal Proceedings

• From time to time the Company may become a party to litigation matters involving claims against the Company.
• Management believes that it is adequately insured for its operations and there are no current matters that would have a material effect on the Company's financial position or results of operations.

Related Party Transactions

• During the six months ended January 31,2025, and 2024 the Company generated revenues of $74,894 and $0 from sales of material to a company controlled by a related party.
• During the six months ended January 31,2025 and 2024, the Company incurred cost of revenues of $20,750 and $0 from services rendered by a subcontractor controlled by a related party.
• As of January 31, 2025 and July 31, 2024, the Company was obliged for accounts payable to one related party, with balances of $1,650 and $0, respectively
• During the six months ended January 31, 2025 and 2024, related parties financed $11,398 and $0 for operation expenses and repaid related parties loan of $10,000 and $33,352, respectively.
• As of January 31, 2025, and July 31, 2024, the Company was obliged for unsecure, non-interest-bearing demand loans to four related parties, with balances of $65,893 and $64,495 respectively.
• During the six months ended January 31, 2025, and 2024, the Company recognized $3,762 and $1,344 interest on related party balances and imputed in additional paid-in-capital, respectively.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern uncertainty.
• Employees may be affected by potential cost-cutting measures or restructuring efforts.
• Customers and suppliers may experience disruptions due to the company's changing business strategy.
• Creditors face increased risk of non-payment due to the company's liquidity challenges.

Next Steps

• The company intends to seek and analyze potential business opportunities and/or combinations in any type of business, industry or geographical location.
• The company intends to fund operations through debt and/or equity financing arrangements and related party advances.
• The company shall have arranged an advance escrow payment to the Issuer in the amount of $2,000,000 by no later than 14 days from full execution of Letter of Intent.

Key Dates